Literature DB >> 16932713

Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinol.

Pascal Richette1, Thomas Bardin.   

Abstract

BACKGROUND: A 56-year-old white woman was referred to our institution with a 16-month history of severe, gouty, recurrent, acute polyarthritis involving the finger joints. She also had numerous small subcutaneous tophi in her hands. The patient was intolerant to allopurinol and had mild renal insufficiency attributed to uric-acid nephrolithiasis and interstitial nephropathy. INVESTIGATIONS: Physical examination, laboratory testing, X-rays of the hands, feet and pelvis, CT of the pelvis, microscopic analysis of an aspirate from a finger tophus. DIAGNOSIS: Tophaceous gout associated with urate nephropathy in a patient intolerant to allopurinol. MANAGEMENT: Acute polyarthritis was successfully managed by intravenous bolus methylprednisolone combined with codeine, diclofenac and low-dose colchicine. Rasburicase infusions combined with fenofibrate and sodium bicarbonate achieved to maintain serum acid uric below 360 micromol/l.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16932713     DOI: 10.1038/ncprheum0214

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN: 1745-8382


  12 in total

1.  Uricases as therapeutic agents to treat refractory gout: Current states and future directions.

Authors:  Xiaolan Yang; Yonghua Yuan; Chang-Guo Zhan; Fei Liao
Journal:  Drug Dev Res       Date:  2011-12-29       Impact factor: 4.360

Review 2.  Update on gout: pathophysiology and potential treatments.

Authors:  Aryeh M Abeles; Jean Y Park; Michael H Pillinger; Bruce N Cronstein
Journal:  Curr Pain Headache Rep       Date:  2007-12

3.  New advances in the treatment of gout: review of pegloticase.

Authors:  Mattheus K Reinders; Tim L Th A Jansen
Journal:  Ther Clin Risk Manag       Date:  2010-10-27       Impact factor: 2.423

Review 4.  Production and Purification of Therapeutic Enzymes.

Authors:  M Ângela Taipa; Pedro Fernandes; Carla C C R de Carvalho
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 5.  Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout.

Authors:  Lisa Cammalleri; Mariano Malaguarnera
Journal:  Int J Med Sci       Date:  2007-03-02       Impact factor: 3.738

6.  Functional and Structural Characterization of Purine Nucleoside Phosphorylase from Kluyveromyces lactis and Its Potential Applications in Reducing Purine Content in Food.

Authors:  Durga Mahor; Anu Priyanka; Gandham S Prasad; Krishan Gopal Thakur
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

7.  Finger pad tophi in a patient with Raynaud phenomenon.

Authors:  Misha Zarbafian; Jan Dutz
Journal:  JAAD Case Rep       Date:  2017-02-01

8.  The Minimal Effect of Linker Length for Fatty Acid Conjugation to a Small Protein on the Serum Half-Life Extension.

Authors:  Jinhwan Cho; Junyong Park; Giyoong Tae; Mi Sun Jin; Inchan Kwon
Journal:  Biomedicines       Date:  2020-04-26

Review 9.  Uricase and other novel agents for the management of patients with treatment-failure gout.

Authors:  John S Sundy; Michael S Hershfield
Journal:  Curr Rheumatol Rep       Date:  2007-06       Impact factor: 4.686

Review 10.  The emerging role of biotechnological drugs in the treatment of gout.

Authors:  L Cavagna; W J Taylor
Journal:  Biomed Res Int       Date:  2014-04-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.